Orexo AB (publ)
OTC: ORXOF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Nikolaj Sorensen
- Employees
- 110
- Headquarters
- Uppsala, Sweden
- IPO year
- 2013
- Market cap
- $73.8M
- Website
- https://www.orexo.com
Loading ORXOF…
Loading profile data…Frequently asked questions about ORXOF
What does Orexo AB (publ) (ORXOF) do?
Orexo AB (publ) functions as a specialized pharmaceutical company, focusing on the innovation, advancement, and marketing of both conventional medicines and digital therapeutic solutions. Its commercial reach extends across the United States, Europe, and the United Kingdom. The firm's existing line of pharmaceutical products includes Zubsolv tab...
Where does ORXOF trade?
Orexo AB (publ) (ORXOF) trades on the Other OTC.
What sector is ORXOF in?
Orexo AB (publ) (ORXOF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Orexo AB (publ)?
Nikolaj Sorensen is the chief executive officer of Orexo AB (publ) (ORXOF).
Where is Orexo AB (publ) headquartered?
Orexo AB (publ) is headquartered in Sweden.
Does ORXOF pay a dividend?
Orexo AB (publ) (ORXOF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ORXOF go public?
Orexo AB (publ) (ORXOF) completed its initial public offering in 2013.